You can Support Project Access this End of Year Season!
We focus on three key areas
Introducing Project ACCESS – A quest to transform access to medication abortion care in clinics nationwide. Project ACCESS, RHAP’s Technical Assistance and training program, supports clinics and clinicians in identifying and overcoming their barriers to providing abortion care.
Applications are now open for the Reproductive Health Care and Advocacy Fellowship! Our fellowship trains family medicine leaders to provide, teach, and advocate for reproductive health care, including abortion. The deadline to apply is September 30th, 2023.
Sign up for Insights, a monthly newsletter offering evidence-based, clinical knowledge on abortion and early pregnancy loss (miscarriage) care. Read our latest Insights on our website.
This factsheet provides a simplified guide for comparing two popular medication methods for an abortion. The factsheet compares and contrasts using mifepristone and misoprostol versus using misoprostol alone. Get answers to questions such as: “How painful is it?”, “Can I still have children after?” and “What will happen?”
Apr 18
Updated April 18, 2023 Nearly three years ago, we celebrated the 20th anniversary of mifepristone and looked back on the history of this medication and how it expanded the options available for those seeking abortion care. French researchers developed mifepristone (also known as RU-486) in the 1980s to be taken with misoprostol for medication abortion…